A supermajority of US physicians say that cannabis is medicinal, and over one-quarter have recommended it to their patients.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Case Series: Whole-Plant Cannabis Extracts Effective in Pediatric Patients with Intractable Epilepsy
“Our data suggest that whole-plant medical cannabis products are superior to isolated CBD products in the patients examined,” investigators reported.
Refusing to hear this case only prolongs the conflicts that currently exist between state laws and federal marijuana laws, NORML’s brief argues.
Scientists concluded, “Our novel findings support the possible therapeutic role of inhaled CBD as an effective, relatively safe, and easy to administer treatment adjunct for GBM.”
Researchers reported that the repeated use of oral CBD products was not associated with liver abnormalities, including the elevated production of certain liver enzymes.
Researchers concluded, “The findings in this paper provide evidence that recreational cannabis dispensaries improved county-level labor market conditions in Colorado.”
Pain patients, on average, reduced their opioid use by nearly one-third, with some of the study’s participants reducing their use by over 40 percent.
All of the products studied tested positive for the presence of heavy metals and none of them provided accurate potency information.